PLXS
Q4 2026 EPS Estimate
$2.56
Oct 28, 2026 · Reports after close
Revenue Estimate
$1.36B
FY2026E EPS$8.69
FY2027E EPS$10.11

Analyst Sentiment

Wall St. Consensus
Hold
18 analysts·Moderate coverage
60
Score
10 Buy (56%)5 Hold (28%)3 Sell (16%)
Rating Breakdown
Strong Buy
00%
Buy
1056%
Hold
528%
Sell
317%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$275.00
+13.7%
Consensus
$310.00
+28.1%
Bull
$330.00
+36.4%
12-Month Target Range18 analysts
$275.00$310.00$330.00
Current $241.91Consensus
Current Price
$241.91
Upside to Consensus
$68.09

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+14.82%
EPS+16.28%
FY2028
Rev+7.49%
EPS+10.30%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$4.90B$5.62B$6.04B
Low$4.89B$5.50B$5.87B
High$4.96B$5.73B$6.30B
EBITDA Avg$316M$363M$390M
Low$316M$355M$379M
High$321M$370M$407M
EBIT Avg$228M$262M$281M
Low$228M$256M$273M
High$231M$267M$293M
Net Income Avg$240M$279M$300M
Low$239M$275M$298M
High$240M$284M$322M
EPS Avg$8.69$10.11$11.15
Low$8.67$9.95$10.81
High$8.70$10.29$11.67
Analysts (Rev / EPS)4 / 33 / 35 / 3
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$1.36B$1.37B$1.39B$1.42B$1.45B$1.46B$1.49B$1.53B
Low$1.35B$1.35B$1.38B$1.41B$1.44B$1.45B$1.48B$1.52B
High$1.37B$1.38B$1.40B$1.43B$1.46B$1.46B$1.50B$1.54B
EBITDA Avg$88M$88M$90M$92M$94M$94M$96M$99M
Low$87M$87M$89M$91M$93M$93M$96M$98M
High$88M$89M$90M$92M$94M$95M$97M$99M
EBIT Avg$63M$64M$65M$66M$67M$68M$69M$71M
Low$63M$63M$64M$66M$67M$67M$69M$71M
High$64M$64M$65M$66M$68M$68M$70M$72M
Net Income Avg$70M$66M$67M$70M$72M$73M$74M$78M
Low$70M$65M$67M$70M$72M$72M$74M$77M
High$70M$67M$68M$71M$73M$73M$75M$78M
EPS Avg$2.55$2.42$2.46$2.57$2.65$2.66$2.71$2.84
Low$2.54$2.36$2.44$2.55$2.63$2.64$2.69$2.82
High$2.56$2.46$2.48$2.59$2.67$2.68$2.73$2.86
Analysts (Rev / EPS)4 / 43 / 41 / 21 / 21 / 21 / 31 / 31 / 3

Earnings Surprises

Recent Analyst Actions

Jun 22, 2026Stifel Nicolaus
Plexus price target raised to $330 from $280 at Stifel
Target:$330.00
+10.0%from $299.97
Jun 1, 2026Needham
Plexus price target raised to $310 from $285 at Needham
Target:$310.00
+15.5%from $268.36
May 26, 2026Stifel Nicolaus
Stifel Reiterates Buy Rating on Plexus (PLXS)
Target:$280.00
+2.8%from $272.29
May 1, 2026Needham
Plexus price target raised to $285 from $206 at Needham
Target:$285.00
+13.7%from $250.58
Apr 30, 2026Raymond James
Plexus price target raised to $275 from $205 at Raymond James
Target:$275.00
+9.7%from $250.58
Apr 20, 2026Stifel Nicolaus
Plexus upgraded to Buy from Hold at Stifel
Target:$250.00
+9.3%from $228.64
Jan 30, 2026Stifel Nicolaus
Plexus price target raised to $200 from $150 at Stifel
Target:$200.00
+1.2%from $197.60
Jan 28, 2026Williams Trading
Plexus price target raised to $195 from $165 at Benchmark
Target:$195.00
+10.5%from $176.40
Oct 24, 2025Stifel Nicolaus
Plexus price target raised to $150 from $140 at Stifel
Target:$150.00
+0.7%from $149.00
Sep 22, 2025Williams Trading
Plexus price target raised to $165 from $160 at Benchmark
Target:$165.00
+14.9%from $143.62
Jul 24, 2025Stifel Nicolaus
Plexus price target lowered to $140 from $145 at Stifel
Target:$140.00
+18.4%from $118.29
Apr 24, 2025Stifel Nicolaus
Plexus price target lowered to $145 from $152 at Stifel
Target:$145.00
+15.7%from $125.35
Oct 1, 2024Williams Trading
Plexus price target raised to $150 from $145 at Benchmark
Target:$150.00
+9.7%from $136.71
Jun 21, 2024Williams Trading
Plexus (PLXS) PT Raised to $120 at Benchmark
Target:$120.00
+16.7%from $102.86
Jul 28, 2023Needham
Plexus' Strength In Commercial Aerospace To Outweigh Demand Issues In Industrial And Healthcare Life Science Market: Analyst
Target:$107.00
+10.6%from $96.72
Aug 29, 2022Williams Trading
Plexus price target raised to $105 from $101 at Benchmark
Target:$105.00
+11.4%from $94.27
Jun 7, 2022Raymond James
Raymond James Upgrades Plexus (PLXS) to Outperform
Target:$100.00
+15.6%from $86.54
Apr 29, 2022Needham
Needham Maintains Buy on Plexus, Raises Price Target to $93
Target:$93.00
+12.6%from $82.60
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.